Understanding Essential Tremor – a clinical overview for health professionals

Essential Tremor (ET) is the most common movement disorder worldwide, affecting roughly 1% of the general population and increasing to about 5% among those over 60.

ET typically affects both arms with a postural or movement-related tremor (frequency 4–12 Hz), while little or no tremor appears at rest. It most often involves the hands and arms, but it can also affect the head, voice and sometimes the legs.

Although ET is not life-threatening, it is a progressive condition. Tremor amplitude gradually increases over time, which can interfere with fine motor tasks, activities of daily living and overall quality of life. The functional impact extends beyond motor symptoms, often affecting emotional wellbeing and social participation.

In Australia, general practitioners (GPs) are usually the first to evaluate patients with ET symptoms. GPs play a key role in recognising the characteristic signs, explaining the condition, initiating early management and coordinating referrals to allied health or specialist services as needed.

ET remains frequently misdiagnosed in practice, most often mistaken for Parkinson’s disease (Parkinson’s) because other causes of tremor (such as medication side effects, hyperthyroidism, menopausal changes, physiological or anxiety-related tremor) can cloud the clinical picture in busy primary care settings.

There are currently no national ET-specific guidelines in Australia, resulting in practice variation across regions. A straightforward, structured approach to diagnosis and management is therefore essential to improve accuracy and consistency of care.

ET classically causes a bilateral action tremor (postural and/or kinetic) in the hands and forearms, often accompanied by tremor in other regions such as the head (~30% of patients) or voice (~20%). The tremor frequency is typically in the range of 4–12 Hz (higher in younger individuals, slightly lower in older patients) and importantly, the tremor is absent or minimal at rest.

ET symptoms usually begin gradually and progress slowly in amplitude over years, while the tremor frequency tends to remain relatively stable. Many patients note that stress, fatigue or caffeine exacerbate the tremor, whereas a modest intake of alcohol often transiently improves it.

Aside from tremor, ET is traditionally considered a monosymptomatic condition. However, mild non-motor features can occur in some individuals, for example, slight impairments in tandem gait or mild cognitive changes, especially in those with longstanding ET.

Approximately half of ET cases have a positive family history, most often consistent with autosomal-dominant inheritance (hence older terms like “familial tremor”).

Clinicians now term such cases “ET-plus”, meaning ET occurs together with soft neurological signs of uncertain significance. Crucially, ET lacks any overt additional neurological deficits. There is no bradykinesia, rigidity, dystonia or other neurological sign that would suggest an alternative diagnosis, primarily PD.

GPs are usually the first to recognise ET and can manage most cases without referral. If the tremor is mild and the diagnosis is straightforward, treatment can begin with simple management strategies and clear patient information. Over time though, if tremor worsens and starts to affect everyday activities like writing, eating, or handling a phone, then next stage strategies such as medication are appropriate.

Early recognition and realistic planning can help prevent frustration for both the patient and clinician.

Treatment should aim to:

  • Support function and daily independence. Even a mild tremor can affect fine motor tasks and confidence in social settings. Improving the quality of life, not eliminating tremor, is the realistic target.
  • Reduce tremor severity with minimal side effects. Pharmacotherapy offers partial relief for many, but not all patients respond and side effects can limit use. Setting expectations early is important.
  • Address the broader psychosocial burden. Many patients feel embarrassment, social anxiety or frustration. These non-motor effects can be more disabling than the tremor itself.

A flexible, multi-pronged approach allows treatment to adapt to each person’s needs, goals and disease progression. It may include lifestyle changes, medication, referrals to allied health professionals, or specialist review if the tremor becomes disabling or atypical in presentation.

Diagnostic criteria

ET is a clinical diagnosis. The current consensus criteria (revised by the International Parkinson and Movement Disorder Society in 2018) require an isolated tremor syndrome of bilateral upper-limb action tremor present for at least 3 years, with no other discernible neurological abnormalities. Tremor may also involve the head, voice or other body parts, but an isolated head or voice tremor without limb involvement is not sufficient for ET.

By definition, there should be no signs of Parkinsonism, dystonia or other neurodegenerative features (except for the possibility of the mild, “plus” features noted below). It is also essential to exclude secondary causes of tremor.

Core clinical features

  • Tremor type: Postural and kinetic (4–12 Hz), absent or minimal at rest.
  • Distribution: Hands (90%), head (30%), voice (20%), legs (rare).
  • Progression: Gradual increase in amplitude; frequency remains relatively stable.
  • Triggers: Exacerbated by stress, fatigue and caffeine; often improves temporarily with alcohol.
  • Family history: Present in ~50–70% of cases; commonly autosomal dominant inheritance.
  • Non-motor features: Some individuals report mild cognitive changes, mood disturbances or subtle gait abnormalities (especially in ET-plus).

Diagnosis

ET is a clinical diagnosis based on:

  • Bilateral upper limb action tremor present for ≥3 years.
  • Absence of other neurological signs (e.g. bradykinesia, rigidity).
  • Exclusion of secondary causes (e.g. medication-induced tremor, hyperthyroidism).
  • Use of bedside tasks (e.g. spiral drawing, handwriting, drinking from a cup) to characterise tremor.
  • Consideration of ET-plus when mild additional neurological signs are present.

Differentiating ET from Parkinson’s

Clinical insights and diagnostic considerations

Feature Essential Tremor (ET) Parkinson’s
Tremor timing Action/postural (during movement) Rest (hands at rest or in lap)
Distribution Bilateral, often symmetrical; hands, head, voice Typically, unilateral onset; hands; rarely head/voice
Frequency Higher (4–12 Hz) Lower (4–6 Hz)
Other symptoms Tremor predominant; mild gait/cognitive changes Bradykinesia, rigidity, postural instability, masked facies
Family history Often present Rare
Alcohol response May improve tremor No effect
Onset age Any age; often middle-aged Typically, >55 years
Pharmacologic response Propranolol, primidone, topiramate Levodopa, dopamine agonists

Clinical insights

  • ET tremor worsens with movement; Parkinson’s tremor is most prominent at rest
  • ET lacks hallmark Parkinsonian features such as rigidity and freezing of gait
  • If diagnostic uncertainty persists, refer to a neurologist specialising in movement disorders and consider DaTscan

From diagnosis to ongoing care

  1. Initial assessment
  • History: onset, triggers, family history, symptoms
  • Neuro exam: rest/postural/kinetic tremor, rule out other signs
  1. Focused evaluation
  • Tremor profile: frequency, axis, amplitude, constancy, regions
  • Provocation tasks: spiral drawing (“Archimedes spirals”), handwriting, object
  1. Rule out mimics
  • Medications, metabolic labs (esp. thyroid)
  • Screen for PD or dystonic features
  1. Diagnosis
  • Bilateral upper limb action tremor
  • Duration >3 years
  • No significant additional neuro signs. These include:
    • Bradykinesia: slowness of movement, especially in initiating voluntary actions
    • Rigidity: stiffness or inflexibility of the muscles
    • Resting tremor (prominent): unless in advanced ET-plus.
    • Postural instability: difficulty maintaining balance or frequent falls
    • Masked facies: reduced facial expression or “masked face”
    • Unequivocal dystonia: sustained or repetitive muscle contractions leading to abnormal postures; subtle or questionable dystonic postures may be accepted only in ET-plus
    • Sudden onset or stepwise deterioration: abrupt onset or rapid worsening suggests another cause, such as a stroke or functional/psychogenic tremor
  1. Management
  • Non-medication: education, OT, stress reduction
  • Medication:
    • First-line: propranolol, primidone
    • Alternatives: topiramate, gabapentin
  • Severe cases: DBS referral and MR focused ultrasound (MRfUS)
  1. Follow-up
  • Monitor progression, function and non-motor symptoms.

Diagnostic clarity: confirming ET and ruling out other conditions

Getting an accurate diagnosis important, not just for managing the condition effectively, but to avoid confusion with other causes of tremor. These can include Parkinson’s, medication side effects, anxiety or hormonal changes, such as those during menopause. Because these conditions can present similar features, especially in early or mild cases, misdiagnosis is common.

Using a clear, structured assessment pathway can improve diagnostic accuracy, support timely referrals and ensure patients receive proper care from the outset.

First-line evaluation (GP-led)

Comprehensive history

  • Include age of onset, symptom progression, affected regions (hands, head, voice), impact on daily function, aggravating/relieving factors (e.g. alcohol responsiveness), family history and medication use.
  • Relevant negative features related to PD

Focused neurological examination

  • Assess tremor features (timing, amplitude, frequency), gait, posture, coordination, tone and reflexes. Observe for signs suggestive of Parkinsonism or dystonia.

Performance tasks

  • Ask the patient to draw a spiral, write, pour water into a cup, or hold arms outstretched. These tasks can accentuate ET and help differentiate it from other tremor types.

Key clinical tests

Observation

  • Look for postural and kinetic tremor during voluntary movement (e.g. drinking, writing).

Spiral drawing test

  • ET often produces a regular, large-amplitude tremor pattern.

Interpreting spiral drawings to differentiate tremor types

Spiral drawing analysis is a simple but informative tool in assessing tremor. Clinicians can use visual inspection to identify patterns that may suggest different underlying causes.

  • A small, tight spiral (micrographia) often points to Parkinson’s disease, particularly when combined with reduced amplitude and progressively smaller loops.
  • Regular, rhythmic oscillations that are more prominent along the 2 o’clock to 8 o’clock axis are characteristic of ET.
  • Irregular, jerky or multidirectional movements within the spiral may indicate a dystonic tremor, especially if there are sudden changes in direction or inconsistent frequency.

Posture and action testing

  • Assess tremor with arms outstretched (postural) and during fine motor tasks (action). A wing-beating position may be revealing of dystonic features.

Finger-to-nose test

  • Helps exclude cerebellar causes, such as intention tremor increasing near the nose, suggesting cerebellar pathology.

Additional neurological signs

  • Screen for bradykinesia, rigidity, or resting tremor, as these features are more common with Parkinson’s.

Rule out secondary causes

Medication review

  • Exclude drug-induced tremor (e.g. lithium, SSRIs, beta-agonists, anticonvulsants).

Metabolic screening

  • Order thyroid function tests; consider metabolic/toxic causes (e.g. hyperthyroidism, liver/kidney dysfunction, heavy metal exposure).

Alcohol and substance use

  • Chronic alcohol misuse, withdrawal and stimulant use may contribute to tremor.

Other diagnoses

  • Sudden onset or rapid progression warrants investigation for structural brain lesions or other movement disorders.

Red flags that suggest an alternative diagnosis or need for referral

Certain features should prompt reconsideration of the diagnosis or referral to a specialist. These include:

  • Asymmetrical rest tremor or signs such as bradykinesia, rigidity or postural instability.
  • Sudden onset of tremor, or a pattern that progresses rapidly or fluctuates markedly.
  • Other neurological changes, for example, unsteady gait, new speech difficulties, or changes in thinking or memory.
  • Unusual age at onset – before 20 or after 80 years.
  • Exposure history – recent use of tremor-inducing medications (e.g. lithium, SSRIs, valproate) or toxins.
  • Psychosocial factors – significant distress, social withdrawal, or functional loss that complicates presentation and daily life.

If any of these are present, re‑check the working diagnosis, rule out secondary causes and consider early neurology input.

Tremor disorders that mimic ET

Disorder Key features How it mimics ET Differentiating clues
Parkinsonian tremor Resting tremor, bradykinesia, rigidity, postural instability May present with action tremor early on Resting tremor, asymmetry, slow movements, DaTscan positive
Dystonic tremor Irregular tremor in the body part affected by dystonia Can be postural/action tremor Jerky quality, “null point” relief and associated dystonic postures
Functional (psychogenic) tremor Variable tremor, distractible, sudden onset Can mimic ET in amplitude and distribution Inconsistent features, entrainment, sudden onset and emotional triggers
Cerebellar tremor Intention tremor, ataxia, dysmetria May appear during movement Worsens near the target (e.g. nose), gait ataxia, scanning speech
Enhanced physiologic tremor Fine, high-frequency tremor Can be mistaken for mild ET Exacerbated by anxiety, caffeine and fatigue; resolves with rest or beta blockers
Rubral tremor (Holmes tremor) Mixed resting, postural and intention tremor May resemble ET in the action phase Slow frequency, associated with brainstem lesions
Orthostatic tremor High-frequency tremor in the legs when standing It may be misinterpreted as ET if the upper limbs are involved Legs affected, improves when sitting, EMG shows >12 Hz frequency
Medication-induced tremor Tremor from drugs like lithium, SSRIs and valproate Can mimic ET in timing and distribution Temporal link to medication, resolves with withdrawal
Wilson’s Disease Wing-beating tremor, dystonia, psychiatric symptoms May resemble ET in young adults Kayser-Fleischer rings, liver dysfunction, copper studies abnormal
Hirayama Disease Postural tremor with distal muscle wasting Can mimic ET in young males Cervical MRI shows spinal cord changes; asymmetric weakness

Clinical insight

Atypical features such as sudden onset, asymmetry, resting tremor or neurological signs should prompt reconsideration of ET and referral. A structured history and focused examination remain the best tools.

ET diagnostic criteria

(Adapted from Australian Clinical Practice)

  • Bilateral action tremor of the upper limbs
  • Duration ≥3 years
  • No other neurological signs (except mild ET-plus features)
  • No secondary cause identified
  • Head or voice tremor may be present, but is not required
  • Family history may support the diagnosis, but it is not essential

When to refer

Referral to a neurologist or movement disorder specialist is recommended when there is:

  • diagnostic uncertainty (e.g. overlapping features with Parkinson’s or dystonia)
  • atypical presentation (e.g. unilateral tremor, sudden onset, rapid progression)
  • poor response to first-line treatment
  • consideration of advanced therapies (e.g. DaTscan, DBS, focused ultrasound)
  • severe functional impairment or Impact on quality of life